Ross Clark

As we have often found with Covid-19, no sooner does a path seem to emerge out of the woods than the trees close in again. On Monday, the Prime Minister confirmed that the further relaxation of lockdown rules – including the reopening of indoor hospitality – would go ahead as planned next week. Daily totals of deaths from Covid-19 have been running at very low levels – indeed deaths from all causes are now running 7.3 per cent lower than the recent five-year average, according to the ONS.

So, the third wave is officially no more. New modelling by SPI-M, the government’s committee on modelling for pandemics, has, at a stroke, eradicated the predicted surge in new infections, hospital admissions and deaths which it had pencilled in for the autumn or winter as a result of lockdown being eased.  Previous modelling published in April suggested that we could end up with 20,000 in hospital — higher than during the first peak last April. Now the third wave is looking less like the swell off Newquay during an Atlantic storm and a little more like a ripple on the Serpentine.

When you are on the side of global enlightenment, the standards of proof required for your assertions tend to be somewhat lower. This perhaps explains why Meghan Markle’s comments during an event called the Global Citizen’s Vax Live concert were so widely reported yet so little challenged by the usual army of self-appointed ‘fact-checkers’ who swoop on anything to do with Covid. She claimed that women 'have been disproportionately affected by this pandemic', citing a 'surge in gender-based violence, the increased responsibility of unpaid care work and new obstacles which have reversed so much progress for women in the workplace'.

Registered Covid deaths fell to just one on Monday, leading many to comment that the epidemic in Britain is effectively over. One day’s statistics don’t mean an awful lot, especially over a bank holiday, but what about the wider picture? Over the UK as a whole, there have been 90 deaths over the past seven days, a fall of 41.2 per cent over the previous seven day period – although that, too, may be affected by the bank holiday. A more in-depth analysis, offering more context – although a little out of date – is provided by the latest weekly analysis of deaths from all causes, published today by the Office for National Statistics and covering the week ending 23 April.

Just how damaging has lockdown been to children’s education? An Oxford University study has tried to quantify it by analysing data from Dutch schoolchildren — who, unlike in Britain where exams were cancelled, took tests shortly before and shortly after the first lockdown last spring. The level of parental education was a big predictor of falling performance If any country’s children had managed to get through lockdown with their education unscathed, suggest the authors, it ought to be those in the Netherlands. There, schools were closed for a relatively short period — eight weeks — and the penetration of broadband in homes is higher than in any other country.

Should we be concerned about the latest React study, which claims that the fall-off in new infections began to plateau from the middle of March? The latest instalment of the monthly study, led by Imperial College, tested a randomised sample of 140,000 volunteers between 11 and 30 March, each of whom was given a PCR test. While the results showed that incidence of infections had fallen by 60 per cent compared with tests conducted between 4 and 23 February, the researchers say that their data shows a flattening-off from mid March. That is interesting because data from the Public health England test and trace system shows a similar pattern: steep falls in new infections during February, followed by a flattening-off in March.

It was the great British scientific triumph: an example of how big pharma can work altruistically for the good of the world, by making a vaccine available at cost price. But is the writing now on the wall for the AstraZeneca vaccine? This afternoon the European Medicines Agency (EMA) ruled that blood clots can be a 'very rare side effect' of the Oxford-AstraZeneca vaccine. It has encouraged health professionals to communicate that 'people receiving the vaccine to remain aware of the possibility of very rare cases of blood clots combined with low levels of blood platelets occurring within two weeks of vaccination.' There may be an age factor as well: 'So far' it reports, 'most of the cases reported have occurred in women under 60 years of age within two weeks of vaccination.